ciltacabtagene autoleucel
janssen
['cartitude-1', 'cartitude', 'mmsm']
impressive progression free survival in cartitude-1 for rrmm presented by although responses are not associated with persistence of car-t product. i m still wondering if we ll see a plateau from a myeloma car. #eha2023 #mmsm 
Haematologist @uclh, Associate Professor @ucl.  Chair UK Myeloma Research Alliance, NCRI Myeloma Group. All views are my own.